Rivia
Rivia is a clinical trial intelligence platform based in Zurich, Switzerland that unifies fragmented clinical trial data from any vendor into a single, structured foundation for biotech and pharmaceutical companies. Its products include Rivia Core (data harmonization), Rivia Detect (AI agents that continuously identify and resolve data quality issues), and Rivia Spark (visual analytics with a conversational AI assistant for exploring trial data through natural language). The platform supports medical and clinical science, safety monitoring, clinical operations, and executive oversight use cases, promising go-live in under 20 days. Rivia raised a $15M Series A and is backed by investors including Earlybird and Speedinvest. The company is a sales-led enterprise platform with no public developer portal or API surface as of this profile; onboarding is via demo request.
Rivia is profiled on the APIs.io network. Tagged areas include Company, Clinical Trials, Healthcare, Life Sciences, and Data Intelligence.
Rivia’s developer surface includes pricing, engineering blog, and 8 more developer resources.
Kin Score
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 3
Authentication, authorization, and security posture
Commercial 3
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API